Latest Alcohols Stories
CANTON, Mass., May 8, 2013 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the presentation of a scientific poster titled "Oxycodone DETERx®, an Extended-release, Abuse-deterrent Formulation for the Management of Chronic Pain," at the American Pain Society's 32(nd) Annual Scientific Meeting, held in New Orleans, Louisiana from May 8(th) to May 10(th). This...
RALEIGH, N.C., May 7, 2013 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Bank of America Merrill Lynch 2013 Health Care Conference. The presentation is scheduled for Tuesday, May 14, 2013 at 5:00 p.m. Pacific Time (8:00 p.m. Eastern Time), at the Encore at Wynn in Las Vegas, Nevada. (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO ) Dr. Sirgo...
redOrbit Staff & Wire Reports - Your Universe Online Pregnant women who have difficulty quitting smoking can take vitamin C to help improve the lung function of her child while also helping to prevent wheezing during the baby’s first year of life, according to a study presented Saturday at the annual meeting of the Pediatric Academic Societies (PAS) in Washington, DC. Lead researcher Cynthia T. McEvoy, an associate professor of pediatrics at Oregon Health & Science University...
BRENTWOOD, England, May 3, 2013 /PRNewswire/ -- - World's first licensed naloxone product for use by non-healthcare profession individuals in a community setting - Prenoxad Injection is a pre-filled syringe containing 1mg/ml naloxone hydrochloride solution for injection Martindale Pharma, a leader in the manufacture and supply of specialty pharmaceuticals , is pleased to announce the UK launch of Prenoxad Injection, the world's...
The all-day "Finding Common Ground in the Gray Zones" workshop is a collaborative effort between San Francisco Health Plan, San Francisco Department of Public Health and San Francisco Community Clinic Consortium that will be held Thursday, May 2nd SAN FRANCISCO, May 2, 2013 /PRNewswire/ -- San Francisco Health Plan (SFHP), a community health plan serving over 80,000 San Francisco residents, is hosting a workshop to help doctors, nurses, pharmacists, and social workers treat chronic...
Pivotal data for investigational controlled release misoprostol vaginal insert in the U.S. accepted for presentation NEW ORLEANS, May 2, 2013 /PRNewswire/ -- Ferring Pharmaceuticals will present efficacy and safety data from its Phase 3 EXPEDITE* study for its investigational controlled release misoprostol vaginal insert (MVI) at the 61(st) annual clinical meeting of the American College of Obstetricians and Gynecologists in New Orleans, May 4 - 8, 2013. Studies accepted for...
Results of a pilot study suggest that a virtual patient advocate (VPA) could help influence positive changes and help women have healthier pregnancies. Developed at Boston University School of Medicine (BUSM), Boston Medical Center (BMC) and Northeastern University, "Gabby" is an innovative tool developed to deliver preconception care (PCC) to African-American women through interactive conversations online. The study results, which are published online in the American Journal of Health...
Over 1,000 chronic pain patients currently on opioids surveyed to understand and quantify the potential market opportunity for Collegium's DETERx® based product candidates CANTON, Mass., April 30, 2013 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the completion of a 1,021 patient survey, which consisted of patients with chronic pain currently on opioid...
Focus on Acute Pain and Uremic Pruritus SHELTON, Conn. and OSAKA, Japan, April 29, 2013 /PRNewswire/ -- Cara Therapeutics, Inc. and Maruishi Pharmaceutical Company, Ltd. (Maruishi) today announced that they have entered into a License Agreement providing Maruishi with exclusive rights to develop, manufacture and commercialize Cara's lead analgesic drug candidate, CR845, for acute pain and uremic pruritus in Japan. CR845 is a highly selective, peptide-based, peripherally-restricted...
Naloxone, an anti-overdose medication, has recently gained attention as legislators are attempting to widen its use in light of the increased abuse of opiates across the US. Malibu, CA (PRWEB) April 26, 2013 Recent legislation has been proposed to address the issue of remedying overdoses caused by opiate drugs, according to a recent article in the Los Angeles Times. The primary anti-overdose drug in question, Naloxone, is a relatively inexpensive generic medication that was approved by...
